Biomarkers in cardiovascular disease

Posted On 2018-01-16 09:32:42

Guest editor: Fabian Sanchis-Gomar, MD, PhD

Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, USA


Biomarkers in the diagnosis, management and prognosis of cardiovascular disease

Fabian Sanchis-Gomar, MD, PhD


Original Article

High-sensitivity cardiac troponin I immunoassay reduces the chance of patient misclassification in the emergency department

Giuseppe Lippi1, Fabian Sanchis-Gomar2,3,4, Rosalia Aloe5, Laura Bonfanti6, Gian Luca Salvagno1, Gianfranco Cervellin6


Review Article

Epigenetic biomarkers in cardiovascular disease

Alejandro Cardona-Monzonís1, Jesús Beltrán-García1,2, José Santiago Ibañez-Cabellos1,2,3, Gisselle Pérez-Machado1,4,5, Kabir Malkani6, Fabian Sanchis-Gomar1,2,6, Salvador Mena-Mollá1,5, José Luis García-Giménez1,2,3,4,5


Circulating Blood Biomarkers in Essential Hypertension: A Literature Review

Amar Shere1,2, Olanrewaju Eletta2, Hemant Goyal1,2


Circulating biomarkers in heart failure: diagnostic and prognostic importance

Alexander E. Berezin1,2


Cardiovascular biomarkers modified by exercise

Sergio López-López1, Helios Pareja-Galeano1,2


More are coming......

The series “Biomarkers in cardiovascular disease” was commissioned by the editorial office, Journal of Laboratory and Precision Medicine without any sponsorship or funding. Fabian Sanchis-Gomar served as the unpaid Guest Editor for the series.